[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 722550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 593605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 433620, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.295, "open": 0.2923, "dayLow": 0.2923, "dayHigh": 0.3088, "regularMarketPreviousClose": 0.295, "regularMarketOpen": 0.2923, "regularMarketDayLow": 0.2923, "regularMarketDayHigh": 0.3088, "payoutRatio": 0.0, "beta": 1.591, "forwardPE": -0.2514876, "volume": 297515, "regularMarketVolume": 297515, "averageVolume": 5774578, "averageVolume10days": 721080, "averageDailyVolume10Day": 721080, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 2491456, "fiftyTwoWeekLow": 0.27, "fiftyTwoWeekHigh": 1.57, "fiftyDayAverage": 0.40176, "twoHundredDayAverage": 0.577255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5743487, "profitMargins": 0.0, "floatShares": 4746838, "sharesOutstanding": 8187500, "sharesShort": 2678655, "sharesShortPriorMonth": 52821, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.32720003, "heldPercentInsiders": 0.16573, "heldPercentInstitutions": 0.18888001, "shortRatio": 0.26, "shortPercentOfFloat": 0.33220002, "impliedSharesOutstanding": 8187500, "bookValue": 1.078, "priceToBook": 0.28228202, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8701076, "trailingEps": -3.66, "forwardEps": -1.21, "lastSplitFactor": "1:12", "lastSplitDate": 1689638400, "enterpriseToEbitda": 0.622, "52WeekChange": -0.6659341, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 0.3043, "targetHighPrice": 10.0, "targetLowPrice": 1.45, "targetMeanPrice": 4.48333, "targetMedianPrice": 2.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 10306888, "totalCashPerShare": 2.041, "ebitda": -9240397, "totalDebt": 3073733, "quickRatio": 2.967, "currentRatio": 3.022, "debtToEquity": 56.485, "returnOnAssets": -0.44133, "returnOnEquity": -1.35369, "freeCashflow": -5641676, "operatingCashflow": -8844435, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.1525505, "regularMarketPrice": 0.3043, "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.164309, "postMarketPrice": 0.3048, "postMarketChange": 0.000499994, "regularMarketChange": 0.009300023, "regularMarketDayRange": "0.2923 - 0.3088", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5774578, "fiftyTwoWeekLowChange": 0.0343, "fiftyTwoWeekLowChangePercent": 0.12703703, "fiftyTwoWeekRange": "0.27 - 1.57", "fiftyTwoWeekHighChange": -1.2657001, "fiftyTwoWeekHighChangePercent": -0.8061784, "fiftyTwoWeekChangePercent": -66.59341, "dividendDate": 1571788800, "earningsTimestamp": 1741865400, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "epsTrailingTwelveMonths": -3.66, "epsForward": -1.21, "epsCurrentYear": -1.65, "priceEpsCurrentYear": -0.18442425, "fiftyDayAverageChange": -0.09746, "fiftyDayAverageChangePercent": -0.24258263, "twoHundredDayAverageChange": -0.272955, "twoHundredDayAverageChangePercent": -0.47284994, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-03-14", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1741996609, "regularMarketTime": 1741982400, "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]